Biocon And Sandoz Join Hands On Japanese Humira Biosimilar
Viatris/Fujifilm Adalimumab Product Was Launched Nearly Three Years Ago
Biocon is looking to tap the global marketing clout of Sandoz by striking a deal to hand over distribution rights to its Humira (adalimumab) biosimilar in Japan.
